NCT07185659 The Effect of Walking Exercise in Patients With Chronic Obstructive Pulmonary Disease
| NCT ID | NCT07185659 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2021-09-09 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2021-09-09 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
"Patients were divided into two groups: the experimental group (E group) and the control group (C group). The E group received standard care, walking exercise, and elastic band exercise, and wore a smart bracelet to record walking steps and sleep for three months. During the first month, participants performed walking exercise for 100 minutes per week and used a red elastic band for resistance training. In the second month, walking exercise increased to 150 minutes per week with a green elastic band. In the third month, walking exercise increased to 150-300 minutes per week with a blue elastic band. The C group wore the smart bracelet to record walking steps and sleep for three months. Each group included 34 participants. The study was conducted from September 9, 2021, to December 31, 2025. Exclusion criteria included panic disorder, cognitive impairment, current cancer treatment, angina pectoris or myocardial infarction within the past 3 months, participation in high-intensity rehabilitation exercise, and walking dysfunction. Participants were required to follow the study protocol. * Assessments\*\*: * Anxiety and Depression\*\*:Measured using the Chinese version of the Hospital Anxiety and Depression Scale (HADS). * Dyspnea\*\*:Measured using the Modified Medical Research Council (mMRC) scale. * Life and Sleep quality\*\*:Measured using the COPD Assessment Test (CAT) and Chinese Version of the Pittsburgh Sleep Quality Index (CPSQI).
Eligibility Criteria
Participants were recruited according to the following criteria. Inclusion Criteria: * Inpatients diagnosed with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. * Age ≥ 40 years. * Post-bronchodilator FEV₁/FVC ratio \< 70%. * History of smoking. * Ability to perform walking exercises. * Willingness of the patient or a family member to provide written informed consent. Exclusion Criteria: * Panic disorder. * Presence of delirium with inability to cooperate. * Currently receiving cancer treatment. * Angina pectoris or myocardial infarction within the past 3 months. * Currently undergoing high-intensity rehabilitation exercises.
Contact & Investigator
Pei-Ching Hung, Hand nurse
PRINCIPAL INVESTIGATOR
Taipei Tzuchi hospital
Frequently Asked Questions
Who can join the NCT07185659 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 100 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07185659 currently recruiting?
Yes, NCT07185659 is actively recruiting participants. Contact the research team at linda8123@hotmail.com for enrollment information.
Where is the NCT07185659 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT07185659 clinical trial?
NCT07185659 is sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. The principal investigator is Pei-Ching Hung, Hand nurse at Taipei Tzuchi hospital. The trial plans to enroll 68 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.